Cargando…

Multipotent Poly(Tertiary Amine‐Oxide) Micelles for Efficient Cancer Drug Delivery

The cancer drug delivery process involves a series of biological barriers, which require the nanomedicine to exhibit different, even opposite properties for high therapeutic efficacy. The prevailing design philosophy, i.e., integrating these properties within one nanomedicine via on‐demand property...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Jiajia, Shen, Yihuai, Zhang, Yifan, Liu, Xin, Zhou, Quan, Zhou, Zhuxian, Tang, Jianbin, Shao, Shiqun, Shen, Youqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036005/
https://www.ncbi.nlm.nih.gov/pubmed/35187868
http://dx.doi.org/10.1002/advs.202200173
_version_ 1784693427305185280
author Xiang, Jiajia
Shen, Yihuai
Zhang, Yifan
Liu, Xin
Zhou, Quan
Zhou, Zhuxian
Tang, Jianbin
Shao, Shiqun
Shen, Youqing
author_facet Xiang, Jiajia
Shen, Yihuai
Zhang, Yifan
Liu, Xin
Zhou, Quan
Zhou, Zhuxian
Tang, Jianbin
Shao, Shiqun
Shen, Youqing
author_sort Xiang, Jiajia
collection PubMed
description The cancer drug delivery process involves a series of biological barriers, which require the nanomedicine to exhibit different, even opposite properties for high therapeutic efficacy. The prevailing design philosophy, i.e., integrating these properties within one nanomedicine via on‐demand property transitions such as PEGylation/dePEGylation, complicates nanomedicines’ composition and thus impedes clinical translation. Here, polyzwitterionic micelles of poly(tertiary amine‐oxide)‐block‐poly(ε‐caprolactone) (PTAO‐PCL) amphiphiles that enable all the required functions are presented. The zwitterionic nature and unique cell membrane affinity confer the PTAO micelles long blood circulation, efficient tumor accumulation and penetration, and fast cellular internalization. The mitochondrial targeting capability allows drug delivery into the mitochondria to induce mitochondrial dysfunction and overcome tumor multidrug resistance. As a result, the PTAO/drug micelles exhibit potent anticancer efficacy. This simple yet multipotent carrier system holds great promise as a generic platform for potential clinical translation.
format Online
Article
Text
id pubmed-9036005
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90360052022-04-27 Multipotent Poly(Tertiary Amine‐Oxide) Micelles for Efficient Cancer Drug Delivery Xiang, Jiajia Shen, Yihuai Zhang, Yifan Liu, Xin Zhou, Quan Zhou, Zhuxian Tang, Jianbin Shao, Shiqun Shen, Youqing Adv Sci (Weinh) Research Articles The cancer drug delivery process involves a series of biological barriers, which require the nanomedicine to exhibit different, even opposite properties for high therapeutic efficacy. The prevailing design philosophy, i.e., integrating these properties within one nanomedicine via on‐demand property transitions such as PEGylation/dePEGylation, complicates nanomedicines’ composition and thus impedes clinical translation. Here, polyzwitterionic micelles of poly(tertiary amine‐oxide)‐block‐poly(ε‐caprolactone) (PTAO‐PCL) amphiphiles that enable all the required functions are presented. The zwitterionic nature and unique cell membrane affinity confer the PTAO micelles long blood circulation, efficient tumor accumulation and penetration, and fast cellular internalization. The mitochondrial targeting capability allows drug delivery into the mitochondria to induce mitochondrial dysfunction and overcome tumor multidrug resistance. As a result, the PTAO/drug micelles exhibit potent anticancer efficacy. This simple yet multipotent carrier system holds great promise as a generic platform for potential clinical translation. John Wiley and Sons Inc. 2022-02-20 /pmc/articles/PMC9036005/ /pubmed/35187868 http://dx.doi.org/10.1002/advs.202200173 Text en © 2022 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Xiang, Jiajia
Shen, Yihuai
Zhang, Yifan
Liu, Xin
Zhou, Quan
Zhou, Zhuxian
Tang, Jianbin
Shao, Shiqun
Shen, Youqing
Multipotent Poly(Tertiary Amine‐Oxide) Micelles for Efficient Cancer Drug Delivery
title Multipotent Poly(Tertiary Amine‐Oxide) Micelles for Efficient Cancer Drug Delivery
title_full Multipotent Poly(Tertiary Amine‐Oxide) Micelles for Efficient Cancer Drug Delivery
title_fullStr Multipotent Poly(Tertiary Amine‐Oxide) Micelles for Efficient Cancer Drug Delivery
title_full_unstemmed Multipotent Poly(Tertiary Amine‐Oxide) Micelles for Efficient Cancer Drug Delivery
title_short Multipotent Poly(Tertiary Amine‐Oxide) Micelles for Efficient Cancer Drug Delivery
title_sort multipotent poly(tertiary amine‐oxide) micelles for efficient cancer drug delivery
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036005/
https://www.ncbi.nlm.nih.gov/pubmed/35187868
http://dx.doi.org/10.1002/advs.202200173
work_keys_str_mv AT xiangjiajia multipotentpolytertiaryamineoxidemicellesforefficientcancerdrugdelivery
AT shenyihuai multipotentpolytertiaryamineoxidemicellesforefficientcancerdrugdelivery
AT zhangyifan multipotentpolytertiaryamineoxidemicellesforefficientcancerdrugdelivery
AT liuxin multipotentpolytertiaryamineoxidemicellesforefficientcancerdrugdelivery
AT zhouquan multipotentpolytertiaryamineoxidemicellesforefficientcancerdrugdelivery
AT zhouzhuxian multipotentpolytertiaryamineoxidemicellesforefficientcancerdrugdelivery
AT tangjianbin multipotentpolytertiaryamineoxidemicellesforefficientcancerdrugdelivery
AT shaoshiqun multipotentpolytertiaryamineoxidemicellesforefficientcancerdrugdelivery
AT shenyouqing multipotentpolytertiaryamineoxidemicellesforefficientcancerdrugdelivery